Rare and Orphan Disease Mouse Models
Search for mouse models by human disease term.
Rare and orphan diseases affect fewer than 200,000 individuals in the United States, and nearly 700,000 rare diseases have been described to date. The Jackson Laboratory offers the world's largest collection of spontaneous, targeted, and transgenic mutant mouse strains, hundreds of which model rare diseases.
Search for mouse models by human disease term.
Discover helpful tools for advancing your rare and orphan disease research.
The Rare and Orphan Disease Center brings together global mouse resources and the expertise of scientists at the Jackson Laboratory for a start-to-finish approach to model development.
Senior Director of JAX Rare and Orphan Disease Center, Cat Lutz, Ph.D., M.B.A. is honored for her tireless efforts in rare...
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord....
Rare and Orphan Disease Research Tools and Online Resources
Resources for people who are interested in learning more about rare diseases, clinical trials, and research programs.
This in-person course is a modern survey of heredity, disease, genetics in experimental animals and humans, and molecular...
Scientists at The Jackson Laboratory (JAX) discussed the dramatic changes that have taken place in the field of genetics...
Families have banded together from across the globe to make awareness and research for SMARD a reality.
Did you know that almost all of us have the sort of genetic mutations that cause rare genetic diseases?
Using the right mouse model can reveal various biological intricacies and may lead to potential therapeutic treatments. In a recent study,...
Efficacy studies are performed by JAX on mouse models for these diseases: C57BL10.mdx and D2.mdx for DMD, DyW for CMD1A, and A/J for...
Rare disease families and experts offer advice on how to navigate the rare disease odyssey.
JAX distributes well-characterized, preclinical mouse models to accelerate drug discovery for rare and orphan diseases.
We engineer new models and enhance existing models through genetic standardization and characterization to ensure reproducibility of data...
We partner with foundations, pharmaceutical and biotech companies, and other scientists to research treatments for uncommon...
JAX has teamed with Lovelace Biomedical, Exemplar Genetics, Iontox and the University of Pennsylvania to win a new $17M contract with the...
New five-year NIH grant totaling $10.6M funds JAX center to fast-track treatment-focused research for rare genetic...
We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.
Allow essential cookies
Required for basic site operations.
Allow analytics cookies
Used to analyze web traffic to improve the user experience.
Allow marketing cookies
Used to deliver personalized information and tailor communications.